Migraine Clinical Trials in Chicago

Showing 61-80 of 121 trials

COMPLETEDPhase 42.2 miles

Efficacy of Erenumab on Functional Impact of Migraine

NCT04465357

The purpose of this study is to assess the efficacy of erenumab on functional impact due to Migraine in adults.

Migraine

Merle Diamond55 participantsStarted Oct 2020

Chicago, Illinois, United States • City of Saint Peters, Missouri, United States • Springfield, Missouri, United States

COMPLETEDPhase 32.2 miles

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

NCT03939312

The purpose of this study is to evaluate the safety and tolerability of atogepant 60 mg once a day for the prevention of migraine in participants with episodic migraine.

Episodic Migraine

Allergan685 participantsStarted May 2019

Chandler, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +110 more locations

Efficacy of Erenumab on Functional Impact of Migraine

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Migraine Trials in Other Cities

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

An Efficacy and Safety Study of Fremanezumab in Adults With Migraine

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

PREMIUM Migraine Trial

Assessment of LBR-101 In Chronic Migraine

MLD10 in the Prevention of Migraine in Adults

Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine

Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine

Study of Pediatric Migraine: The Pediatric Migraine Registry

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Musculoskeletal Impairment in Headaches Attributed to Rhinosinusitis

Efficacy and Safety of BGG492 in the Treatment of Migraine

Other Conditions in Chicago